LYKALABS vs RPGLIFE: Stock Comparison

LYKALABS vs RPG LIFE SCIENCESUpdated 1 Jul 26, 4:08 PM ISTNSE & company filings

RPG LIFE SCIENCES is the larger company by market capitalisation. LYKALABS shows a lower P/E, while RPG LIFE SCIENCES shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

LYKALABS leads 3; RPGLIFE leads 9 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

LYKALABSRPGLIFE

Valuation lens

What price are you paying?

Market CapContext only
₹285 Cr
₹4,515 Cr
P/E RatioLYKALABS has the lower reading
0x
51.42x
P/B RatioLYKALABS has the lower reading
2.67x
7.03x
EPSRPGLIFE has the higher reading
₹0.57
₹18.6
Book ValueContext only
₹25.12
₹366.03
Dividend YieldRPGLIFE has the higher reading
0%
0.91%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
RPGLIFE is the larger company
₹4,515 Cr vs ₹285 Cr
P/E Ratio
LYKALABS has a lower P/E
0x vs 51.42x
P/B Ratio
LYKALABS has a lower P/B
2.67x vs 7.03x
EPS
RPGLIFE has higher earnings per share
₹18.6 vs ₹0.57
Dividend Yield
RPGLIFE has a higher dividend yield
0.91% vs 0%
Revenue Growth (TTM YoY)
RPGLIFE has faster revenue growth
23.6% vs 0%
EPS Growth (TTM YoY)
LYKALABS has faster EPS growth
0% vs -74.5%
Qtr Profit Growth
RPGLIFE has stronger quarterly profit growth
0.62% vs -2.56%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricLYKALABSRPGLIFE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricLYKALABSRPGLIFE
Live Price₹74.83₹2,721.6
Day Change1.19%2.61%
Volume88,55620,463
52-Week High₹101.99₹3,082
52-Week Low₹44.1₹1,733
Distance from 52W High-26.63%-11.69%

Valuation

MetricLYKALABSRPGLIFE
Market Cap₹285 Cr₹4,515 Cr
P/E Ratio0x51.42x
P/B Ratio2.67x7.03x
EPS₹0.57₹18.6
Book Value₹25.12₹366.03
Dividend Yield0%0.91%

Growth

MetricLYKALABSRPGLIFE
Revenue Growth (TTM YoY)0%23.6%
EPS Growth (TTM YoY)0%-74.5%
Qtr Sales Growth0%0%
Qtr Profit Growth-2.56%0.62%

Profitability & Leverage

MetricLYKALABSRPGLIFE
ROE-37.11%19.02%
ROCE-22.29%24.39%
Net Margin-7.81%29.25%
Operating Margin-24.74%21.92%
Debt to Equity0.56x0.03x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricLYKALABSRPGLIFE
Promoter Holding58.45% 0.29 pp72.95%
FII Holding0.17% 0.12 pp0.95% 0.08 pp
DII Holding0.66% 0.01 pp8.67% 1.22 pp
Public Holding40.72% 0.16 pp17.42% 1.31 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: LYKALABS and RPG LIFE SCIENCES.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.